4-(2-(di-n-propylamino)ethyl)-2(3H)-indolone,
Requip,
ropinirol,
ropinirole,
ropinirole hydrochloride,
SK and F 101468,
SK and F-101,468,
SKF 101468,
Ropinirole hydrochloride,
Ropinirole HCl,
91374-20-8,
ReQuip,
4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride,
ReQuip XL,
Ropinirole (hydrochloride),
UNII-D7ZD41RZI9,
SKF 101468 hydrochloride,
Ropinirole hydrochloride [USAN:USP],
SK&F 101468-A,
D7ZD41RZI9,
SKF-101468A,
MFCD01754173,
SK&F-101468A,
4-(2-(Dipropylamino)ethyl)-2-indolinone monohydrochloride,
ReQuip CR,
4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride,
1,3-Dihydro-4-(2-(dipropylamino)ethyl)-2H-indol-2-one monohydrochloride,
4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one hydrochloride,
4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one hydrochloride,
4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one hydrochloride,
2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride,
SK&F-101468-A,
SR-01000076215,
4-[2-(dipropylamino)ethyl]indolin-2-one hydrochloride,
Adartrel,
Repreve,
Requi,
4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride,
Ropinirole hydrochloride [USAN],
ReQuip LP,
ReQuip PR,
ReQuip XR,
Requip (TN),
Ropinirolhydrochloride,
ropinirole-hydrochloride,
Ropinirole hydrochloride/,
Ropinirole hydrochloride;,
AC1L2ABS,
AC1Q3EQJ,
JZP-7,
SCHEMBL40760,
MLS003899234,
CHEBI:8889,
CHEMBL1200411,
CTK8B7890,
HY-B0623A,
KS-00002WRZ,
DTXSID50238533,
NVD-434,
XDXHAEQXIBQUEZ-UHFFFAOYSA-N,
ACT02690,
BCP02130,
EBD38503,
Tox21_501101,
91374-21-9 (base),
ABP000199,
AC-735,
AC-736,
ANW-58872,
FC0024,
NP-201,
Ropinirole hydrochloride (JAN/USAN),
s3189,
AKOS015844988,
BS-1020,
CCG-213346,
CS-2864,
HP-3000,
LP01101,
MCULE-8190476072,
KS-000011L6,
NCGC00094373-01,
NCGC00261786-01,
4CA-1107,
AK-59618,
AN-15584,
BC207366,
LS-83828,
SMR001456484,
AB0009822,
TC-030791,
TL8005858,
EU-0101101,
FT-0642200,
ST24042825,
SW199044-2,
A11916,
D00784,
M-1298,
R 4152,
91374-20-8,91374-21-9(freebase),
374R208,
A843815,
Ropinirole hydrochloride, powder, >=98% (HPLC),
I06-0693,
SR-01000076215-2,
SR-01000076215-5,
4-(2-Dipropylamino-ethyl)-1,3-dihydro-indol-2-one,
4-(2-di-n-propylaminoethyl)-2(3H)indolone hydrochloride,
Z1695926158,
4-(2-di-n-propylaminoethyl)-2(3H)-indolone hydrochloride,
4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone Hydrochloride,
Ropinirole hydrochloride, EuropePharmacopoeia (EP) Reference Standard,
2H-Indol-2-one, 1,3-dihydro-4-(2-(dipropylamino)ethyl)-, monohydrochloride,
Ropinirole for peak identification 1, EuropePharmacopoeia (EP) Reference Standard,
Ropinirole for peak identification 2, EuropePharmacopoeia (EP) Reference Standard,
Ropinirole Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Ropinirole hydrochloride, United States Pharmacopeia (USP) Reference Standard,
SKF 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride,
ropinirole,
Ropinirolehydrochloride,
C16H25ClN2O,
C16H24N2O.HCl,
ROPINIROLE, HYDROCHLORIDE,
C16-H24-N2-O.Cl-H,
CID68727,
AR-1L3132,
ACN-030249,
CS-O-11740,
91374-20-8 (HCl),
B2129,
1-Methyl-5-nitroimidazole-2-methanol Carbamate,
91374-21-9,
4-(2-(Dipropylamino)ethyl)indolin-2-onehydrochloride,
973-34-2,